Literature DB >> 21295149

Behavioral analysis of NR2C knockout mouse reveals deficit in acquisition of conditioned fear and working memory.

Brandon G Hillman1, Subhash C Gupta, Dustin J Stairs, Andres Buonanno, Shashank M Dravid.   

Abstract

N-methyl-D-aspartate (NMDA) receptors play an important role in excitatory neurotransmission and mediate synaptic plasticity associated with learning and memory. NMDA receptors are composed of two NR1 and two NR2 subunits and the identity of the NR2 subunit confers unique electrophysiologic and pharmacologic properties to the receptor. The precise role of NR2C-containing receptors in vivo is poorly understood. We have performed a battery of behavioral tests on NR2C knockout/nβ-galactosidase knock-in mice and found no difference in spontaneous activity, basal anxiety, forced-swim immobility, novel object recognition, pain sensitivity and reference memory in comparison to wildtype counterparts. However, NR2C knockout mice were found to exhibit deficits in fear acquisition and working memory compared to wildtype mice. Deficit in fear acquisition correlated with lack of fear conditioning-induced plasticity at the thalamo-amygdala synapse. These findings suggest a unique role of NR2C-containing receptors in associative and executive learning representing a novel therapeutic target for deficits in cognition.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21295149      PMCID: PMC3432405          DOI: 10.1016/j.nlm.2011.01.008

Source DB:  PubMed          Journal:  Neurobiol Learn Mem        ISSN: 1074-7427            Impact factor:   2.877


  77 in total

Review 1.  NMDA receptor subunits: diversity, development and disease.

Authors:  S Cull-Candy; S Brickley; M Farrant
Journal:  Curr Opin Neurobiol       Date:  2001-06       Impact factor: 6.627

2.  Developmental profile of the changing properties of NMDA receptors at cerebellar mossy fiber-granule cell synapses.

Authors:  L Cathala; C Misra; S Cull-Candy
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

Review 3.  The glutamate receptor ion channels.

Authors:  R Dingledine; K Borges; D Bowie; S F Traynelis
Journal:  Pharmacol Rev       Date:  1999-03       Impact factor: 25.468

4.  Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning.

Authors:  R G Phillips; J E LeDoux
Journal:  Behav Neurosci       Date:  1992-04       Impact factor: 1.912

Review 5.  Management of negative symptoms of schizophrenia.

Authors:  D C Javitt
Journal:  Curr Psychiatry Rep       Date:  2001-10       Impact factor: 5.285

6.  Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats.

Authors:  David L Walker; Kerry J Ressler; Kwok-Tung Lu; Michael Davis
Journal:  J Neurosci       Date:  2002-03-15       Impact factor: 6.167

7.  Subdissociative dose ketamine produces a deficit in manipulation but not maintenance of the contents of working memory.

Authors:  Rebekah A E Honey; Danielle C Turner; Garry D Honey; Sam R Sharar; D Kumaran; E Pomarol-Clotet; P McKenna; B J Sahakian; T W Robbins; P C Fletcher
Journal:  Neuropsychopharmacology       Date:  2003-11       Impact factor: 7.853

Review 8.  Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence.

Authors:  P J Harrison; D R Weinberger
Journal:  Mol Psychiatry       Date:  2005-01       Impact factor: 15.992

9.  Activation of recombinant NR1/NR2C NMDA receptors.

Authors:  Shashank M Dravid; Anand Prakash; Stephen F Traynelis
Journal:  J Physiol       Date:  2008-07-17       Impact factor: 5.182

10.  An animal model of emotional blunting in schizophrenia.

Authors:  Charmaine Y Pietersen; Fokko J Bosker; Janine Doorduin; Minke E Jongsma; Folkert Postema; Joseph V Haas; Michael P Johnson; Tineke Koch; Tony Vladusich; Johan A den Boer
Journal:  PLoS One       Date:  2007-12-26       Impact factor: 3.240

View more
  38 in total

1.  Essential role of GluD1 in dendritic spine development and GluN2B to GluN2A NMDAR subunit switch in the cortex and hippocampus reveals ability of GluN2B inhibition in correcting hyperconnectivity.

Authors:  Subhash C Gupta; Roopali Yadav; Ratnamala Pavuluri; Barbara J Morley; Dustin J Stairs; Shashank M Dravid
Journal:  Neuropharmacology       Date:  2015-02-24       Impact factor: 5.250

Review 2.  Glutamatergic regulation of cognition and functional brain connectivity: insights from pharmacological, genetic and translational schizophrenia research.

Authors:  Maria R Dauvermann; Graham Lee; Neil Dawson
Journal:  Br J Pharmacol       Date:  2017-08-11       Impact factor: 8.739

3.  D-cycloserine facilitation of cognitive behavioral therapy for delusions in schizophrenia.

Authors:  Jennifer D Gottlieb; Corinne Cather; Meghan Shanahan; Timothy Creedon; Eric A Macklin; Donald C Goff
Journal:  Schizophr Res       Date:  2011-06-30       Impact factor: 4.939

Review 4.  D-cycloserine: an evolving role in learning and neuroplasticity in schizophrenia.

Authors:  Donald C Goff
Journal:  Schizophr Bull       Date:  2012-02-23       Impact factor: 9.306

5.  Synthesis and structure activity relationship of tetrahydroisoquinoline-based potentiators of GluN2C and GluN2D containing N-methyl-D-aspartate receptors.

Authors:  Rose M Santangelo Freel; Kevin K Ogden; Katie L Strong; Alpa Khatri; Kathryn M Chepiga; Henrik S Jensen; Stephen F Traynelis; Dennis C Liotta
Journal:  J Med Chem       Date:  2013-06-20       Impact factor: 7.446

6.  Potentiation of GluN2C/D NMDA receptor subtypes in the amygdala facilitates the retention of fear and extinction learning in mice.

Authors:  Kevin K Ogden; Alpa Khatri; Stephen F Traynelis; Scott A Heldt
Journal:  Neuropsychopharmacology       Date:  2013-09-06       Impact factor: 7.853

7.  Structure-activity relationships and pharmacophore model of a noncompetitive pyrazoline containing class of GluN2C/GluN2D selective antagonists.

Authors:  Timothy M Acker; Alpa Khatri; Katie M Vance; Cathryn Slabber; John Bacsa; James P Snyder; Stephen F Traynelis; Dennis C Liotta
Journal:  J Med Chem       Date:  2013-08-02       Impact factor: 7.446

8.  Region-specific Expression of NMDA Receptor GluN2C Subunit in Parvalbumin-Positive Neurons and Astrocytes: Analysis of GluN2C Expression using a Novel Reporter Model.

Authors:  Aparna Ravikrishnan; Pauravi J Gandhi; Gajanan P Shelkar; Jinxu Liu; Ratnamala Pavuluri; Shashank M Dravid
Journal:  Neuroscience       Date:  2018-03-17       Impact factor: 3.590

9.  GluN2C/GluN2D subunit-selective NMDA receptor potentiator CIQ reverses MK-801-induced impairment in prepulse inhibition and working memory in Y-maze test in mice.

Authors:  P S Suryavanshi; R R Ugale; D Yilmazer-Hanke; D J Stairs; S M Dravid
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

10.  Prefrontal Cortex-Mediated Impairments in a Genetic Model of NMDA Receptor Hypofunction Are Reversed by the Novel M1 PAM VU6004256.

Authors:  Michael D Grannan; Catharine A Mielnik; Sean P Moran; Robert W Gould; Jacob Ball; Zhuoyan Lu; Michael Bubser; Amy J Ramsey; Masahito Abe; Hyekyung P Cho; Kellie D Nance; Anna L Blobaum; Colleen M Niswender; P Jeffrey Conn; Craig W Lindsley; Carrie K Jones
Journal:  ACS Chem Neurosci       Date:  2016-10-05       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.